Table of Contents 3
List of Tables 5
List of Figures 5
Epigenomics AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Epigenomics AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Epigenomics AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Epigenomics AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Epigenomics AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Epigenomics AG, Medical Equipment, Deal Details 11
Partnerships 11
Biochain Institute Enters into Licensing Agreement with Epigenomics 11
Epigenomics And BioChain Expand Licensing Agreement For Septin9 12
Biochain Institute Enters Into Licensing Agreement With Epigenomics For Septin9 13
Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker 14
Epigenomics Enters Into Commercialization Agreement With Polymedco For Epi proColon 15
Epigenomics And Wuhan Kindstar Enter Into Licensing Agreement For Epi Prolung 16
Equity Offering 17
Epigenomics to Raise Funds Through Rights Offering of Shares 17
Epigenomics Raises USD6.5 Million in Private Placement of Shares 18
Epigenomics Files Draft Registration Statement for US Public Offering of Shares 19
Epigenomics Raises USD5.6 Million in Rights Offering of Shares 20
Epigenomics Raises USD5.3 Million in Private Placement of Shares 21
Epigenomics Completes Private Placement Of Shares For US$4.5 Million 23
Epigenomics Announces Private Placement Of Shares For US$1.3 Million 24
Epigenomics Completes Rights Issue Of Common Stock For US$6 Million 25
Epigenomics Completes Private Placement Of Shares For US$0.7 Million 26
Debt Offering 27
Epigenomics Raises USD8.5 Million in Private Placement of Bonds 27
Epigenomics Announces Private Placement Of Bonds For US$6.7 Million 28
Acquisition 29
Cathay Fortune International to Acquire Epigenomics 29
Epigenomics AG - Key Competitors 31
Epigenomics AG - Key Employees 32
Epigenomics AG - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Aug 08, 2018: Epigenomics Announces 2018 Second Quarter and Six Month Financial Results 34
May 09, 2018: Epigenomics announces 2018 First Quarter Financial Results 35
Mar 23, 2018: Epigenomics Reports Results for Financial Year 2017 36
Nov 15, 2017: Epigenomics Announces 2017 Third Quarter and Nine Months Financial Results 38
Aug 09, 2017: Epigenomics Announces 2017 Second Quarter and Six Months Financial Results 39
Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017 40
May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results 41
Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016 42
Corporate Communications 43
Nov 29, 2017: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive VP Finance and a Member of the Management Board (Vorstand) 43
Nov 08, 2017: Epigenomics Appointment of Director Reimbursement and Medical Affairs 44
Nov 05, 2017: Supervisory Board of Epigenomics Appoints Dr. Jorge Garces as President and Chief Scientific Officer 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Epigenomics AG, Medical Equipment, Key Facts, 2017 2
Epigenomics AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Epigenomics AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Epigenomics AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Epigenomics AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Epigenomics AG, Deals By Market, 2012 to YTD 2018 9
Epigenomics AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biochain Institute Enters into Licensing Agreement with Epigenomics 11
Epigenomics And BioChain Expand Licensing Agreement For Septin9 12
Biochain Institute Enters Into Licensing Agreement With Epigenomics For Septin9 13
Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker 14
Epigenomics Enters Into Commercialization Agreement With Polymedco For Epi proColon 15
Epigenomics And Wuhan Kindstar Enter Into Licensing Agreement For Epi Prolung 16
Epigenomics to Raise Funds Through Rights Offering of Shares 17
Epigenomics Raises USD6.5 Million in Private Placement of Shares 18
Epigenomics Files Draft Registration Statement for US Public Offering of Shares 19
Epigenomics Raises USD5.6 Million in Rights Offering of Shares 20
Epigenomics Raises USD5.3 Million in Private Placement of Shares 21
Epigenomics Completes Private Placement Of Shares For US$4.5 Million 23
Epigenomics Announces Private Placement Of Shares For US$1.3 Million 24
Epigenomics Completes Rights Issue Of Common Stock For US$6 Million 25
Epigenomics Completes Private Placement Of Shares For US$0.7 Million 26
Epigenomics Raises USD8.5 Million in Private Placement of Bonds 27
Epigenomics Announces Private Placement Of Bonds For US$6.7 Million 28
Cathay Fortune International to Acquire Epigenomics 29
Epigenomics AG, Key Competitors 31
Epigenomics AG, Key Employees 32
Epigenomics AG, Subsidiaries 33

List of Figures
Epigenomics AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Epigenomics AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Epigenomics AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Epigenomics AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Epigenomics AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Epigenomics AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Epigenomics AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Epigenomics AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9